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Background: Persistent somatic symptoms are associated with psychological distress,
impaired function, and medical help-seeking behavior. The Patient Health Questionnaire
(PHQ)-15 is used as a screening instrument for somatization and as a monitoring
instrument for somatic symptom severity. A bifactorial model has been described, with
one general factor and four orthogonal specific symptom factors. The objective of the
present study was to assess and to clarify the factor structure of the PHQ-15 within and
between different countries in Western Europe and China.
Method: Cross-sectional secondary data analysis performed in three patient data
samples from two Western European countries (Germany N = 2,517, the Netherlands
N = 456) and from China (N = 1,329). Confirmatory factor analyses (CFA), and structural
equation modeling (SEM) analysis were performed.
Results: The general factor is found in every sample. However, although the outcomes of
the PHQ-15 estimate severity of somatic symptoms in different facets, these subscales
may have different meanings in the European and Chinese setting. Replication of the
factorial structure was possible in the German and Dutch datasets but not in the dataset
from China. For the Chinese dataset, a bifactorial model with a different structure for
the cardiopulmonary factor is suggested. The PHQ-15 could discern somatization from
anxiety and depression within the three samples.
Conclusion: The PHQ-15 is a valid questionnaire that can discern somatization from
anxiety and depression within different cultures like Europe or China. It can be fitted to
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a bifactorial model for categorical data, however, the model can only be recommended
for use of the general factor. Application of the orthogonal subscales in non-European
samples is not corroborated by the results. The differences cannot be ascribed to
differences in health care settings or by differences in concomitant depression or anxiety
but instead, a cultural factor involving concepts of disease may play a role in this as
they may play a role in the translation of the questionnaire. Further research is needed
to explore this, and replication studies are needed regarding the factorial structure of the
PHQ-15 in China.
Keywords: somatic symptoms, patient health questionnaire-15, factor structure, structural equation modeling
(SEM), transcultural
BACKGROUND
Somatic Symptoms, Emotional Distress,
and Disability
In everyday life, somatic symptoms are common causes of
outpatient medical visits (1, 2). Patients with multiple distressing
somatic symptoms present themselves in a variety of health
care settings, such as primary, secondary and tertiary patient-
centers (3–6). Poor self-rated health of patients was found to
be associated with multiple somatic symptoms in Europe and
in China (7–10). The number of somatic symptoms correlates
well with impaired function and medical help-seeking behavior
even after controlling for mental disorders (5). The number of
somatic symptoms differs only slightly between patients with
somatic symptoms explained by a medical disease and patients
with unexplained somatic symptoms (11, 12). This indicates that
the suffering of a patient with medically unexplained somatic
symptoms should be taken seriously. In Western countries, a
high number of somatic symptoms is associated with higher
psychological distress, more functional impairment, higher
disability, more health care utilization and a reduced quality
of life (13–15). Given the large burden of somatic symptoms,
especially unexplained symptoms that are currently not taken
sufficiently seriously, the assessment of somatic symptoms and
the analysis of the different facets of somatic symptoms is a useful
and necessary part of every medical diagnostic process.
The Patient Health Questionnaire (PHQ)-15
The Patient Health Questionnaire (PHQ)-15 (16) is a short,
practical self-rating instrument for the screening of somatic
symptoms. The PHQ-15 has also been suggested by the
DSM-5 Workgroup on Somatic Symptom Disorders (SSD)
as a measurement tool of somatic symptom severity for the
classification of SSD (17, 18). The PHQ-15 was initially validated
in primary care and a general hospital setting in the USA (16).
Although usually the sum score is simply used as a measure
for symptom load, several studies (16, 19–21) suggest that the
different somatic symptoms in the PHQ-15 can be divided and
bundled into four groups: cardiopulmonary, gastrointestinal,
pain, and fatigue/general symptoms.
Witthöft et al. (22) assessed the underlying structure of
the PHQ-15 in two datasets of college students (Germany,
N = 1,520; Switzerland, N = 3,053). They conducted a
confirmatory factor analysis assuming a bifactor model (1 general
and 4 orthogonal specific symptom factors; gastrointestinal,
fatigue, cardiopulmonary, and pain symptoms). Correlations
with general and lower-order latent factors of depression, general
somatic symptom distress, and health anxiety were found. These
factors explain up to nearly 70% of the variance in the general
somatic symptom factor. However, it remains to be shown if this
structure also applies to other samples. The original validation
of the PHQ-15 was in general hospital patients and primary
care patients (16), but not in patients in specialty mental health
institutions, so it would be useful to explore the factor structure
in other health care settings such as the specialty mental health
care setting.
Also, it is unclear whether the factor structure of the PHQ-
15 questionnaire is comparable between samples from Europe
and samples from other continents and cultures such as Asia,
in particular China, since the cultural background shapes the
interpretation of somatic symptoms and thereby influences an
individual’s illness perception and illness behavior (23, 24). In the
literature, the influence of culture on experiencing somatic as well
as psychosomatic symptoms has been explored. Evidence exists
that cultural and personal explanatory models can contribute
to the symptomatology of medically unexplained symptoms
(25). Efforts have been made to make epidemiological research
into this domain possible (26) and the need for appropriate
instruments to assess physical symptoms in the context of distress
in Asian cultures has been expressed (27).
Historically, there has been a popular belief that Asians
manifest a lower prevalence of mood and anxiety disorders
than their Western counterparts because they are more prone
to experiencing and manifesting distress via somatic pathways
(28–30). Among Chinese patients receiving psychiatric services,
somatic symptoms such as pain, insomnia, and fatigue have been
associated with depressive and anxiety disorders (31).
The PHQ-15 has been translated into many other languages
and has been examined in samples from many other countries,
e.g., Saudi Arabia, Spain, and Korea (32–34). This offers the
potential for comparisons between different ethnic, cultural or
geographical groups. However, so far, no studies have explored
the factor structure in the context of different health care settings
and West European vs. Chinese culture.
Another point of discussion concerns somatization.
Somatization is defined as the tendency to experience and
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to express physical distress and symptoms that cannot be
explained by pathological findings, to attribute them to a medical
condition, and to seek medical care for them (35). It has also been
described as a term related to our conceptualisation of disease,
that is, to the tendency of doctors to attribute symptoms either
to physically explainable medical conditions, or as medically
unexplained symptoms (36). It has been suggested that physical
symptoms occurring in the context of somatization may also
concur with depression or anxiety (37). Hence, somatization, as
assessed by PHQ-15, might be related to anxiety or depression
as assessed by GAD-7 and PHQ-9, as somatization, anxiety,
and depression are supposed to be related. It was hypothesized
that this might be the case in China, as somatization has been
assumed to be more common in China as a manifestation of
underlying anxiety and depression (38). Hence, the association
between scores on the PHQ-15 and GAD-7 and PHQ-9 should
be explored in these different cultures.
Rationale and Aims of the Study
In this study, we compare patients with SSD including all
kinds of psychosomatic illnesses in a convenience sample from
three different countries, namely Germany, the Netherlands, and
China, that enabled us to compare three different health care
settings, namely the general hospital inpatient psychosomatic
setting (Germany), the specialty mental health outpatient setting
providing treatment for SSRD patients with high complexity
levels in terms of diagnostic problems, treatment issues and
social challenges (8), in the Netherlands; and the general hospital
(China) for SSD. Finally, this way we could compare two different
cultures, namely the Western European and the Chinese culture.
The objective of the present study was to assess and to clarify
the factor structure of the PHQ-15 within and between different
countries.
We aimed to answer the following research questions:
(1) Can the proposed bifactor model of Witthöft et al. (22) be
replicated in three different study populations?
(2) If not—are there more appropriate models within the three
study populations?
(3) Are there indications for cultural differences?
(4) Is there an association between PHQ-9 and GAD-7 scores
and the Witthöft factorial structure of the PHQ-15? More
specifically, is there an association between PHQ-9 and
GAD-7 scores and the potential general factor and/or the
specific factors of the PHQ-15?
METHODS
Study Design
This is a cross-sectional, secondary analysis of data collected
within several research projects or routine clinical care in the
three countries. In Germany, the data were collected as part of
routine clinical care. In China, the data were collected as part of
a cross sectional study (39) in the general hospital setting. In the
Netherlands, the data were collected as part of routine clinical
care in the Clinical Centre of Excellence of BodyMind andHealth
(8, 40–42).
Assessment Instruments
PHQ-15
The PHQ-15 is a self-administered somatic symptoms subscale
derived from the full PHQ (14, 43). The PHQ-15 was originally
validated by Spitzer et al. (16). It includes 15 prevalent somatic
symptoms that represent over 90% of the symptoms observed in
primary care (16). The patients are asked to rate the severity of
their symptoms during the previous 4 weeks on a 3-point scale
as either 0 (“not bothered at all”), 1 (“bothered a little”) or 2
(“bothered a lot”). The questionnaire demonstrated good internal
consistency [Cronbach’s alpha= 0.80; (16)] and high relevance to
symptoms. It is available in multiple languages.
Germany
The German translation of the PHQ-15 has been shown to have
sound psychometric properties (44) and reference data from the
general population is available (45). The PHQ-15, as well as
the PHQ-9 and the GAD-7, were collected within the routine
psychometric assessment of outpatients in the Department
of Psychosomatic Medicine. Data analyzed here has been
collected between January 2005 and February 2009. If patients
were assessed multiple times, we included the first occasion
only. Clinical diagnoses were made by trained physicians and
psychologists. Along with questionnaires and clinical diagnoses,
we collected sociodemographic data.
China
The validity and reliability of the Chinese version of the PHQ-15
(46) were examined in the general population of Hong Kong. The
Hong Kong version of the PHQ-15 exhibited satisfactory internal
consistency (Cronbach’s alpha = 0.79) and stable 1-month
test-retest reliability. Somatic symptom severity was positively
associated with functional impairment and health service use.
In Mainland China, the validity and reliability of the PHQ-
15 were tested in the outpatient clinics of general hospitals
in Shanghai (47). Cronbach’s alpha was 0.73, and the test-
retest reliability coefficient was 0.75 (10). There were moderate
positive correlations between the PHQ-15 score and anxiety and
depression values.
Translation of the PHQ-15
Three native Chinese speakers who resided in Germany updated
the Chinese version of the PHQ-15 taking findings from recent
research into account. The translation was based on the former
Chinese version, which was translated from English to Mandarin
(47). The differences to this former version include changes in
item 1 and item 8: We changed “stomach pain” (胃痛或肚痛) in
item 1 to “stomach and abdominal pain” (胃痛), in accordance
to the suggestions of Lee, Ma (46). In item 8, “fainting spells” was
replaced with “brief fainting” [短倒 (Cantonese), 短时间晕倒
(Mandarin)]. The Mandarin version of the PHQ-15 used in this
study is available in the Appendix (Supplementary Material).
The data analyzed here were taken from a cross-sectional
survey under routine clinical conditions. Participants in this
study were inpatients recruited from different departments
(e.g., oncology, cardiology, respiratory medicine, rehabilitation,
geriatrics and gerontology, general practice, pain management,
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thyroid and breast surgery, rheumatology, and hepatic surgery).
The validation of the PHQ-15 is a component of a larger project
investigating the prevalence and recognition of inpatients with
emotional distress and their treatment needs at a general hospital.
Ethics Statement
All patients were informed at intake that the Patient Related
OutcomeMonitoring (PROM) data pertaining to their treatment
could be used on an anonymous basis for research, and were
provided the opportunity to object to that during intake or
anytime during treatment. PROM data of patients objecting to
this were not used in this study. The study was approved by
the ethics committees of the Shanghai Dong Fang hospital (XZ),
the University Medical Centre Freiburg (KF), and GGz Breburg
(CFC).
The Netherlands
In the Netherlands, the PHQ-15 was applied in several research
projects in primary care (48, 49), occupational health care (50),
and the general hospital setting (51). In primary care, the PHQ-
15 showed limited results in terms of validity (52) as it was
found to have a tendency to be falsely positive for somatoform
disorder, as it does not discern unexplained physical symptoms
from explained physical symptoms. In occupational health care,
validity was also limited both in terms of sensitivity as well
as in terms of specificity (53). It is currently regularly applied
in the intake procedure of the Clinical Centre of Excellence
for Body, Mind, and Health (Dutch abbreviation: CLGG),
which is a specialty mental health institution for patients with
somatic symptom and related disorders. Data from this patient
group is included in this comparative study. Before intake,
patients at CLGG receive questionnaires using Routine Outcome
Monitoring. Data for this study were collected during 2010 and
2016. A total of 465 patients filled in the PHQ-15, GAD-7, and
PHQ-9.
Depression Scale PHQ-9
This instrument assesses each of the nine DSM-IV depression
criteria on a scale of “0” (not at all) to “3” (nearly every
day) (13). The PHQ-9 demonstrated acceptable psychometric
properties for the screening of patients with late-life depression.
In the Netherlands, the PHQ-9 was validated in the Depression
Initiative, a national study aimed at improvingmental health care
for people with depressive symptoms. It proved to be a feasible
and valid instrument to screen for depressive disorder, to assess
severity and to assess change in scores over time in the primary
care, occupational health care and general hospital outpatient
setting. It has also been proven to be feasible and valid for use in
electronic monitoring systems in the context of blended mental
health care in the occupational health setting. The PHQ-9 is a
widely used and valid instrument in the Netherlands as well as in
Germany (54–56).
In Chinese, within a primary care setting, this questionnaire
showed a sensitivity of 0.86 and a specificity of 0.77 for depression
screening (57).
Anxiety Scale (GAD-7)
A seven-item anxiety scale (GAD-7) was used to assess the
severity of generalized anxiety (58). In a German validation study
(59), it has been shown to be a reliable and valid measure of
anxiety in the general population. In a study in the Dutch primary
Care setting, it showed limited validity as a screener and better
validity as a case-finding instrument for general practitioners (60)
and it proved to be feasible in the application of collaborative
care in the primary care setting. In a Chinese general hospital
population, this instrument showed good reliability and good
criterion, construct, factorial, and procedural validity (23).
Statistical Analyses
Using IBM SPSS (24.0) (61), and MPlus (62) 7.4 software, all
three samples were analyzed using confirmatory factor analyses
(CFA) and structural equation modeling (SEM). As the items
of all questionnaires were categorical ordered the analyses were
conducted with the robust weighted least squares estimator
with a mean and variance adjusted test statistic (WLSMV).
Because the chi-square test is sensitive to potentially irrelevant
deviations from the implied model structure given large samples,
we used established fit measures to evaluate the models. For
the absolute fit, we chose the root mean square error of
approximation (RMSEA). The comparative fit index (CFI) and
the TLI (Tucker–Lewis Index) are reported as incremental fit
indices. Following the advice of Hu and Bentler (63) RMSEA
values lower than 0.06 and CFI/TLI values higher than 0.95 are
considered as indicators of a good model fit. All coefficients (i.e.,
factor loadings and path weights) are reported as standardized
coefficients.
Several CFA models were tested. In a first step, the bifactor
model from Witthöft, Fischer (22) was estimated within a
multigroup design. Because model fit was only acceptable,
alternative models were sought in a second step. In this
second step, the bifactor model [see Figure 1 (Germany),
Figure 2 (Netherlands), and Figure 3 (China)] was estimated
within each group and modification indices were assessed
to improve fit indices over abovementioned cutoffs. In a
third step, SEMs consisting of measurement models and a
structural model was computed in order to determine the
size of associations between the latent factors implied by the
bifactor model and other relevant constructs (GAD-7 and
PHQ-9).
RESULTS
Description of the Sample
Age and gender in the three samples are shown in Table 1.
The age and gender are comparable in the dataset from
Germany and the Netherlands but the participants from China
are significantly older, with a range of up to over 90 years, and
have significantly more male participants. This may have to do
with the fact that for both Germany and the Netherlands, but not
in China, separate health services exist for patients older than 70
years.
The distributions of the PHQ-15 items within the three
samples (Germany N = 2,517, China N = 1,329, Netherlands N
= 456) are presented in Table 2.
Some items (e.g., PHQ8 [fainting spells] and PHQ11 [pain
or problems during sexual intercourse]) have a bottom or floor
effects so a metric scale cannot be assumed.
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FIGURE 1 | A bilateral model of somatic symptoms in the PHQ-15 in Germany, N = 2,517. With standardized factor loadings and standard error in parenthesis. Circle
represents latent variables, squares refer to manifest variables, single headed arrows represent factor loadings, double headed arrows represent correlations.
CFA Models for the Three Samples Taken
Together
First, the bifactor model from Witthöft et al. (22) consisting of a
general symptom distress factor and four orthogonal symptom-
specific factors was estimated within a multigroup design. Our
Model showed an acceptable but not excellent model fit in
the three samples taken together. The Chi-Square-Test of the
model fit was 1850.013 (df = 214, p < 0.0001) with a Chi-
Square contribution from the German data of 1081.462, China
about 531.294 and the Netherlands 237.257. The RMSEA was
0.073 (90%C.I. = 0.070, 0.076). With a CFI of 0.928 a TLI of
0.921, the first model only has an acceptable fit but not a good
model fit.
Hence, a secondmodel was explored assuming that the factors
might not be completely independent, allowing for correlations
between the four symptom-specific factors to be unequal to
zero, in which the four symptom-specific factors would not be
orthogonal anymore. This second model was explored over the
three groups taken together again.
The Chi-Square-Test of the model fit was 641.186 (df = 46, p
< 0.0001). The RMSEAwas about 0.055 (90%C.I.= 0.051, 0.059).
With a CFI of 0.980, a TLI of 0.965, this model had a better fit
but the MPlus results showed that the latent variable covariance
matrix was not positive definite for the Chinese sample, not for
the whole model. Hence, a satisfactory fit for the three samples
taken together could not be established.
CFA Model for the Separate Datasets
We split the dataset into the three datasets or Germany, China,
and the Netherlands, and searched some specific model per
country and special sample within these countries.
Germany
Starting with the German dataset, we tried a model comparable
to Witthöft et al. (22) but allowing for correlations between the
four symptom-specific factors. The Chi-Square-Test of the fit for
this final German model was 265.638 (df = 46, p < 0.0001). The
RMSEA was about 0.044 (90%C.I. = 0.039, 0.049). With a CFI
of 0.983, a TLI of 0.971. The model therefore fits in the German
dataset. The only difference between Witthöft et al. (22) are the
low but essential correlations between the factors. Without these
correlations, the model would not fit. The results of this model
are shown in Tables 2a,b. Almost all correlations between the
four factors were significant. Two factors (Pain and Cardio) have
a correlation of about −0.546; the others have a lower absolute
value. The model is shown in Figure 1.
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FIGURE 2 | A bilateral model of somatic symptoms in the PHQ-15 in Netherlands, N = 456.With standardized factor loadings and standard error in parenthesis.
Circle represents latent variables, squares refer to manifest variables, single headed arrows represent factor loadings, double headed arrows represent correlations.
The Netherlands
For the dataset from the Netherlands, explorative testing
and using the modification indices showed that only a
little change for item 6 (chest pain) had to be done (see
Tables 3a,b). In the original model, this item belongs to pain-
related symptoms. For our model, this item fits better to the
cardiopulmonary-related symptoms factor. The Chi-Square-Test
of the fit for the final Dutch model was 53.624 (df = 46, p
= 0.2051). The RMSEA was about 0.019 (90%C.I. = 0.000,
0.038; probability of RMSEA ≤ 0.05 is = 0.999). With a
CFI of 0.998, a TLI of 0.997. The model is shown in
Figure 2.
China
The structure from Witthöft et al. (22) could not be replicated
in the dataset from China. We split the cardiopulmonary-
related symptoms factor into two factors. These factors were
correlated but estimate different latent variables. In the model
for this dataset the pain-related symptoms factor includes
items PHQ2 (back pain), PHQ3 (pain arm legs), and PHQ6
(chest pain), and the gastrointestinal-related symptoms factor
includes items PHQ1 (stomach pain), PHQ5 (headaches),
PHQ12 (constipation), and PHQ13 (nausea, gas). The first
cardiopulmonary-related symptoms factor only includes items
PHQ7 (dizziness) and PHQ10 (short breath), while the second
cardiopulmonary-related symptoms factor is measured by PHQ6
(chest pain), PHQ8 (fainting spells), and PHQ11 (pain sexual
intercourse) (see Tables 4a,b). The fatigue-related symptoms
factor includes items PHQ14 and PHQ15. The Chi-Square-Test
of the fit for the final Chinese model was 187.779 (df = 41,
p < 0.0001). The RMSEA was about 0.052 (90%C.I. = 0.045,
0.060; probability of RMSEA ≤ 0.05 is = 0.325). A CFI of 0.977,
a TLI of 0.957, show a good fit of the model, as shown in
Figure 3.
A part of the results from the different models—the thresholds
between the points on the scale of the PHQ-15 items—can be
interpreted and compared between the different countries. The
results in Table 5 reflect the descriptive in Table 1 where the
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FIGURE 3 | A bilateral model of somatic symptoms in the PHQ-15 in China, N = 1,329. With standardized factor loadings and standard error in parenthesis. Circle
represents latent variables, squares refer to manifest variables, single headed arrows represent factor loadings, double headed arrows represent correlations.
TABLE 1 | Demographic characteristics.
Germany China Netherlands F/Chi2 df p R2
Total N 2,517 1,322 456
Age Mean 42.56 53.76 41.02 259.68 df1 = 2 df2 = 4,292 <0.001 0.108
SD 15.13 16.21 12.65
Gender Male (N) 782 771 167
(%) 31.10% 58.10% 36.60% 266.27% 2 <0.001
Female (N) 1,735 557 289
(%) 68.90% 41.90% 63.40%
participants from the different samples respond differently. This
diversity leads to different thresholds in the three samples. They
can be deduced from Table 1 and are shown in the Table below.
For example, in the PHQ-15 item 3 the thresholds for both
European samples are nearly the same while the thresholds for
the sample from China are substantially higher. However, for
all used PHQ-15 items there are thresholds, which show that all
three points of the used 3-point scale are useful. This is shown in
Table 5.
PHQ-9 and GAD-7
We then tested the predictive value of the PHQ-9 and
the GAD-7 questionnaires within these models. Within the
German and the Chinese sample the PHQ-9 had good
prediction values for most PHQ-15 factors while the GAD-7
predicted the general factor and the fatigue factor well. In the
sample from the Netherlands, only the general factor is well-
predicted by the PHQ-9 and the GAD-7. This is shown in
Table 6.
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TABLE 2 | Descriptive statistics for the items of the PHQ15 for all three samples.
Germany
(N = 2,517)
China
(N = 1,329)
Netherlands
(N = 456)
PHQ1
stomach pain
Not bothered at all
Bothered a little
Bothered a lot
47.9 % 1,206
25.9% 651
26.2% 660
69.0% 917
25.3% 336
5.7% 76
39.1% 175
42.6% 191
18.3% 82
PHQ2
back pain
Not bothered at all
Bothered a little
Bothered a lot
30.1% 757
29.6% 746
40.3% 1,014
55.2% 733
36.7% 488
8.1% 108
29.6% 135
40.8% 186
29.6% 135
PHQ3
pain in your arms, legs, or joint
Not bothered at all
Bothered a little
Bothered a lot
32.2% 811
28.3% 712
39.5% 994
52.9% 703
34.5% 458
12.6% 168
26.5% 121
36.8% 168
36.6% 167
PHQ5
headaches
Not bothered at all
Bothered a little
Bothered a lot
32.3% 814
37.1% 935
30.5% 768
65.4% 869
30.1% 400
4.5% 60
66.9% 305
24.1% 110
9.0% 41
PHQ6
chest pain
Not bothered at all
Bothered a little
Bothered a lot
53.4% 1,344
27.7% 698
18.9% 650
64.0% 850
30.8% 409
5.3% 70
32.5% 148
43.2% 197
24.3% 111
PHQ7
dizziness
Not bothered at all
Bothered a little
Bothered a lot
36.2% 912
37.9% 955
25.8% 650
57.0% 758
38.3% 509
4.7% 62
57.0% 260
30.7% 140
12.3% 56
PHQ8
fainting spells
Not bothered at all
Bothered a little
Bothered a lot
84.3% 2,121
10.2% 257
5.5% 139
83.4% 1,109
13.2% 175
3.4% 45
41.0% 187
40.4% 184
18.6% 85
PHQ10
shortness of breath
Not bothered at all
Bothered a little
Bothered a lot
46.0% 1,158
31.9% 804
22.1% 555
67.0% 891
25.7% 342
7.2% 96
50.4% 230
36.2% 165
13.4% 61
PHQ11
pain or problems during sexual intercourse
Not bothered at all
Bothered a little
Bothered a lot
69.9% 1,751
13.7% 345
16.7% 421
82.7% 1,099
13.8% 184
3.5% 46
38.2% 174
45.0% 205
16.9% 77
PHQ12
constipation, loose bowels, or diarrhea
Not bothered at all
Bothered a little
Bothered a lot
41.0% 1,033
31.1% 783
27.9% 701
50.6% 672
39.3% 522
10.2% 135
37.7% 172
43.4% 198
18.9% 86
PHQ13
nausea, gas, or indigestion
Not bothered at all
Bothered a little
Bothered a lot
34.1% 858
32.7% 822
33.3% 837
51.5% 685
39.3% 522
9.2% 122
20.8% 95
59.2% 270
20.0% 91
PHQ14
feeling tired or having low energy
Not bothered at all
Bothered a little
Bothered a lot
8.6% 216
28.6% 720
62.8% 1,581
36.0% 479
50.8% 675
13.2% 175
22.4% 102
41.7% 190
36.0% 164
PHQ15
trouble sleeping
Not bothered at all
Bothered a little
Bothered a lot
12.5% 314
25.9% 651
61.7% 1,552
43.5% 578
40.8% 542
15.7% 209
7.0% 19
18.1% 49
74.8% 202
Only three categories of possible answers exist within the PHQ15.
DISCUSSION
This study examines the factor structure of the PHQ-15 in a
cross country and cross cultural setting involving China, with
a total of 4302 participants. It shows that the factor structure
found by Witthöft et al. (22) consisting of a general symptom
distress factor and four orthogonal symptom-specific factors
(pain-, gastrointestinal-, cardiopulmonary-, and fatigue-related
symptoms) does not fit the full sample consisting of all three
study populations.
An analysis per sample showed similarities with the Witthöft
model in the German and the Dutch population. In the German
sample the model of Witthöft could be replicated if low but
essential correlations between the factors were allowed. We
find a comparable but different model for the dataset from the
Netherlands. The Dutch sample showed an excellent fit with the
original model if item 6 was adapted belonging to pain-related
symptoms toward fitting this item to the cardiopulmonary-
related symptoms factor.
However, the Witthöft model could not be replicated in the
Chinese sample. There were differences in pain, in the sense that
the cardiovascular item chest pain was mostly reported in the
context of general pain symptoms. Also, items like fainting, chest
pain and problems with sexual intercourse were related, contrary
to the European samples. Hence the Chinese sample seems to
have different properties compared to the European samples.
This may be due to epidemiological differences, such as that
cardiovascular symptoms were reported and experienced in the
context of sexual symptoms. But it might also be associated with
cultural differences in body and illness perception, or in scripting,
as described by Kleinman (64); a script concerning a specific
clustering of symptoms may be shared by patients and Chinese
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Table 2a | Fitting solution in the German sample.
General Factor (S.E.) Factor PAIN (S.E.) Factor GASTRO (S.E.) Factor CARDIO (S.E.) Factor FATIGUE (S.E.)
PHQ1 0.466 (0.023) 0.415 (0.026)
PHQ2 0.573 (0.025) 0.596 (0.045)
PHQ3 0.509 (0.026) 0.626 (0.046)
PHQ5 0.579 (0.020) −0.058 (0.029)
PHQ6 0.623 (0.019) −0.015 (0.033)
PHQ7 0.675 (0.023) 0.381 (0.045)
PHQ8 0.577 (0.034) 0.514 (0.056)
PHQ10 0.592 (0.020) 0.003 (0.038)
PHQ11 0.377 (0.028) −0.227 (0.041)
PHQ12 0.465 (0.026) 0.667 (0.026)
PHQ13 0.553 (0.025) 0.729 (0.028)
PHQ14 0.592 (0.023) 0.479 (0.056)
PHQ15 0.507 (0.026) 0.743 (0.081)
Table 2b | Correlations between the factors within the German sample.
Factor GASTRO Factor CARDIO Factor FATIGUE
Factor PAIN −0.081 (0.052) p = 0.118 −0.546 (0.080) p < 0.001 0.065 (0.052) p = 0.209
Factor GASTRO −0.247 (0.066) p < 0.001 0.171 (0.046) p < 0.001
Factor CARDIO −0.305 (0.081) p < 0.001
Table 3a | Fitting solution in the sample from the Netherlands.
General Factor (S.E.) Factor PAIN (S.E.) Factor GASTRO (S.E.) Factor CARDIO (S.E.) Factor FATIGUE (S.E.)
PHQ1 0.449 (0.097) 0.704 (0.073)
PHQ2 0.568 (0.082) 0.750 (0.142)
PHQ3 0.684 (0.054) 0.370 (0.139)
PHQ5 0.499 (0.055) 0.208 (0.097)
PHQ6 0.810 (0.045) 0.158 (0.157)
PHQ7 0.612 (0.096) 0.450 (0.138)
PHQ8 0.665 (0.062) 0.268 (0.135)
PHQ10 0.610 (0.093) 0.429 (0.140)
PHQ11 0.339 (0.144)
PHQ12 0.397 (0.084) 0.567 (0.071)
PHQ13 0.390 (0.089) 0.630 (0.066)
PHQ14 0.756 (0.053) 0.285 (0.153)
PHQ15 0.480 (0.079) 0.441 (0.142)
Table 3b | Correlations between the factors within the sample from the Netherlands.
Factor GASTRO FCARDIO FFATIGUE
FPAIN 0.400 (0.172) p = 0.020 0.405 (0.206) p = 0.049 0.433 (0.244) p = 0.076
FGASTRO 0.519 (0.138) p < 0.001 0.444 (0.230) p = 0.054
FCARDIO 0.509 (0.292) p = 0.082
mental health professionals and this might be one of such scripts.
Ryder and Chentsova-Dutton (65) describe so-called “scripts”as
. . . “organized units of culturally salient knowledge, such as
knowledge about the ways in which one communicates distress. . .
based on observation as well as formal learning.. Scripts serve
as mechanisms for rapid, automatic retrieval of information and
recognition of patterns. . . .Once scripts are enacted they are
observable by others as behavior and become elements of the
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Table 4a | Fitting solution in the Chinese sample.
General Factor (S.E.) Factor PAIN (S.E.) Factor GASTRO (S.E.) Factor CARDIO1 (S.E.) Factor CARDIO2 (S.E.) Factor FATIGUE (S.E.)
PHQ1 0.587 (0.041) 0.389 (0.060)
PHQ2 0.532 (0.036) 0.620 (0.065)
PHQ3 0.470 (0.033) 0.315 (0.051)
PHQ5 0.872 (0.046) −0.168 (0.074)
PHQ6 0.587 (0.034) 0.301 (0.050) 0.254 (0.051)
PHQ7 0.708 (0.033) 0.112 (0.066)
PHQ8 0.532 (0.042) 0.547 (0.067)
PHQ10 0.415 (0.044) 0.623 (0.184)
PHQ11 0.443 (0.044) 0.443 (0.066)
PHQ12 0.419 (0.046) 0.509 (0.047)
PHQ13 0.498 (0.052) 0.656 (0.049)
PHQ14 0.491 (0.048) 0.730 (0.046)
PHQ15 0.473 (0.038) 0.471 (0.043
Table 4b | Correlations between the factors within the Chinese sample.
Factor GASTRO Factor CARDIO1 Factor CARDIO2 Factor FATIGUE
Factor PAIN 0.337 (0.089) p < 0.001 0.447 (0.165) p = 0.007 −0.017 (0.122) p = 0.892 0.473 (0.078) p < 0.001
Factor GASTRO 0.407 (0.149) p = 0.006 0.217 (0.095) p = 0.003 0.619 (0.059) p < 0.001
Factor CARDIO1 0.585 (0.194) p = 0.003 0.668 (0.209) p = 0.001
Factor CARDIO2 −0.045 (0.116) p = 0.697
TABLE 5 | Thresholds between the different steps on the 3-point scale of the
PHQ-15.
Germany
threshold (S.E.)
China threshold
(S.E.)
Netherlands
threshold (S.E.)
PHQ1 1 to 2 −0.052 (0.025) 0.496 (0.036) −0.278 (0.060)
PHQ1 2 to3 0.637 (0.027) 1.579 (0.056) 0.904 (0.069)
PHQ2 1 to 2 −0.522 (0.026) 0.130 (0.034) −0.536 (0.062)
PHQ2 2 to3 0.246 (0.025) 1.397 (0.050) 0.536 (0.062)
PHQ3 1 to 2 −0.462 (0.026) 0.073 (0.034) −0.627 (0.069)
PHQ3 2 to3 0.267 (0.025) 1.144 (0.044) 0.342 (0.060)
PHQ5 1 to 2 −0.485 (0.026) 0.396 (0.035) 0.437 (0.061)
PHQ5 2 to3 0.510 (0.026) 1.694 (0.060) 1.341 (0.083)
PHQ6 1 to 2 0.085 (0.025) 0.357 (0.035) −0.455 (0.061)
PHQ6 2 to3 0.883 (0.029) 1.619 (0.057) 0.695 (0.064)
PHQ7 1 to 2 −0.352 (0.026) 0.177 (0.035) 0.177 (0.059)
PHQ7 2 to3 0.649 (0.027) 1.678 (0.059) 1.161 (0.076)
PHQ8 1 to 2 1.005 (0.030) 0.972 (0.041) −0.227 (0.059)
PHQ8 2 to3 1.596 (0.041) 1.827 (0.066) 0.891 (0.068)
PHQ10 1 to 2 −0.100 (0.025) 0.441 (0.036) 0.011 (0.059)
PHQ10 2 to3 0.771 (0.028) 1.459 (0.052) 1.109 (0.074)
PHQ11 1 to 2 0.512 (0.026) 0.942 (0.041) −0.301 (0.060)
PHQ11 2 to3 0.965 (0.030) 1.817 (0.065) 0.959 (0.070)
PHQ12 1 to 2 −0.226 (0.025) 0.014 (0.034) −0.313 (0.060)
PHQ12 2 to3 0.587 (0.027) 1.237 (0.047) 0.883 (0.068)
PHQ13 1 to 2 −0.410 (0.026) 0.039 (0.034) −0.812 (0.066)
PHQ13 2 to3 0.433 (0.026) 1.330 (0.048) 0.843 (0.067)
PHQ14 1 to 2 −1.367 (0.036) −0.357 (0.035) −0.760 (0.065)
PHQ14 2 to3 −0.327 (0.025) 1.118 (0.043) 0.359 (0.060)
PHQ15 1 to 2 −1.152 (0.032) −0.164 (0.035) −1.473 (0.115)
PHQ15 2 to3 −0.297 (0.025) 1.006 (0.042) −0.669 (0.083)
larger cultural context” (66). In their elaboration, they refer to
Kleinman and Kleinman who explain the meaning of scripts as
potentially influenced by political events such as the Cultural
Revolution. In this way, symptoms of distress i.e., depression
could have dangerous connotations if expressed as such (67, 68)
and thus lead to different scripts for distress (68).
Thus, cultural scripts (66) shape the ways in which people
attend and react to particular experiences marked as important
in some way. In some cases, pathological loops can form, where
attention to a particular symptom can accentuate its severity and
give rise to related symptoms’ (65).
Another explanation may be fear of stigma; if sexual
intercourse would be experienced as problematic, it might be
reported in the context of symptoms suggesting cardiovascular
disease, and not as standalone. A connection between shame
and stigma has been reported for schizophrenia (69). The role
of stigma in recognition of mental disorders in China has been
explored (70). The literature indicates that higher rates of shyness
and other normal interpersonal concerns in Chinese cultural
contexts exist (71). Such shame may also play a role in sexual
problems if it occurs in the context of unrecognized mental
disorder, and thus in the reporting of physical symptoms in SSD.
Regarding a possible association between factor structure and
health care settings, this was considered as a possibility because
somatic symptoms may be perceived as providing more effective
access to health care resources (38), however, this does not
seem to be corroborated by the results. The German and Dutch
samples seem to be congruent although from different health
care settings, namely a general hospital setting and a specialized
mental health care setting for SSD. The Chinese sample also
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TABLE 6 | Different factors predicted by PHQ-9 and GAD-7.
Factor Germany China Netherlands
PHQ-9 GAD PHQ-9 GAD-7 PHQ-9 GAD-7
Est. (SE) p Est. (SE) p Est. (SE) p Est. (SE) p Est. (SE) p Est. (SE) P
General 0.348 (0.027) <0.001 0.433 (0.029) <0.001 0.168 (0.043) <0.001 0.211 (0.038) <0.001 0.178 (0.059) 0.002 0.167 (0.061) 0.006
Pain 0.027 (0.020) 0.171 0.019 (0.020) 0.331 0.160 (0.068) 0.019 0.108 (0.061) 0.080 0.000 (0.002) 0.980 0.035 (0.065) 0.595
Gastro 0.057 (0.020) 0.004 0.017 (0.015) 0.254 0.206 (0.046) <0.001 0.093 (0.035) 0.009 0.036 (0.039) 0.357 0.010 (0.023) 0.648
Cardio 0.085 (0.043) 0.049 0.087 (0.057) 0.123 0.076 (0.047) 0.107 0.027 (0.027) 0.315 0.068 (0.056) 0.224 0.055 (0.058) 0.337
Fatigue 0.763 (0.030) <0.001 0.886 (0.035) <0.001 0.402 (0.046) <0.001 0.384 (0.047) <0.001 0.036 (0.074) 0.623 0.001 (0.004) 0.988
Annotation: For this comparison we use only the second cardio factor within the sample from China. Significant regression weights are printed in bold.
concerns a general hospital setting, but the Chinese sample shows
a different factorial structure from the European samples.
This different factorial structure in the Chinese sample
does not seem to be explained by different associations
with depression and anxiety either, as both the German
and the Chinese sample showed that the PHQ-9 had good
predictive values for most PHQ-15 factors while the GAD-7
well-predicted the general factor and the fatigue factor. In
contrast, the sample from the Netherlands found the PHQ-9
and the GAD-7 to be only predictive for the PHQ-15 general
factor.
The findings of this study suggest that the different factorial
structure of the PHQ-15 in China is not to be explained
by differences in concomitant depression or anxiety. Cultural
factors such as stigma, scripting, or different concepts of disease
(36), may play a role in this. Further research is needed to
explore this, and replication studies are needed regarding the
factorial structure of the PHQ-15 in China. Nevertheless, with
this knowledge the PHQ15 can be applied in China, taking this
small difference in somatic symptom clusters for China into
account. Future studies should also explore to what extend the
different factorial structures might bias data analysis when the
PHQ-15 is used as a unidimensional measure. Furthermore, they
should investigate whether any confounding factors could be
identified which drive the differences between cultures.
Limitations of the study
It can be considered a limitation of the study that health
care settings and culture differences overlap and hence their
assessment cannot be separated sufficiently to enable firm
conclusions in this matter.
CONCLUSION
The PHQ-15 is a valid questionnaire that can discern
somatization from anxiety and depression within different
cultures like Europe or China. The questionnaire can be fitted
to a bifactorial model, however, we can only recommend the use
of the general factor. Application of the orthogonal subscales in
non-European samples is not corroborated by the results. Further
research is needed to explore explanations and to replicate the
findings of this study.
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